TGFB1 and myeloid sarcoma: Our results suggest that a differing susceptibility and clinical course in MS is caused by different Treg, Th17 and Th9 cell polarization determined by the TGFβ, IL6, IFNγ and IL4 cytokine pathway interactions which vary between men and women (Figure 3 and 4).